GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis-Reference-Cited by-同舟云学术

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Published:2020-03 Issue:3 Volume:18 Page:728-735.e4
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Best Jan,Bechmann Lars P.,Sowa Jan-Peter,Sydor Svenja,Dechêne Alexander,Pflanz Kristina,Bedreli Sotiria,Schotten Clemens,Geier Andreas,Berg Thomas,Fischer Janett,Vogel Arndt,Bantel Heike,Weinmann Arndt,Schattenberg Jörn M.,Huber Yvonne^ORCID,Wege Henning,von Felden Johann^ORCID,Schulze Kornelius,Bettinger Dominik,Thimme Robert,Sinner Friedrich,Schütte Kerstin,Weiss Karl Heinz,Toyoda Hidenori,Yasuda Satoshi,Kumada Takashi^ORCID,Berhane Sarah,Wichert Marc,Heider Dominik,Gerken Guido,Johnson Philip,Canbay Ali^ORCID

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference35 articles.

1. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates;Younossi;Clin Gastroenterol Hepatol,2019

2. Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis;Ertle;Int J Cancer,2011

3. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

4. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis;Bolondi;Gut,2001

5. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis;Del Poggio;Clin Gastroenterol Hepatol,2014

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision;Journal of Clinical and Experimental Hepatology;2024-11

2. Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration;Frontiers in Pharmacology;2024-09-02

3. Point-based risk score for the risk stratification and prediction of hepatocellular carcinoma: a population-based random survival forest modeling study;eClinicalMedicine;2024-09

4. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

5. The trajectory of vesicular proteomic signatures from HBV‐HCC by chitosan‐magnetic bead‐based separation and DIA‐proteomic analysis;Journal of Extracellular Vesicles;2024-08-29